76838 Federal Register / Vol. 89, No. 182 / Thursday, September 19, 2024 / Notices 

including for emergency response 

events. 

III. Under part C, Section C–B, 

Organization and Functions, delete the 

respective mission or functional 

statements for and replace with the 

following: 

Meningitis, Pertussis, and Diphtheria 

Epidemiology Branch (CJEC). (1) 

provides epidemiologic subject matter 

expertise and technical assistance for 

surveillance, prevention, and control of 

bacterial illness, including 

meningococcal disease, Haemophilus 

influenzae disease, diphtheria, 

pertussis, tetanus, and bacterial 

meningitis syndrome; (2) develops, 

implements, and evaluates prevention 

strategies for these bacterial diseases, 

including vaccine and non-vaccine 

strategies; (3) supports development of 

vaccine policy through the ACIP 

process; (4) conducts surveillance and 

epidemiological research for 

meningococcal disease, H. influenzae 

disease, diphtheria, pertussis, tetanus, 

and bacterial meningitis syndrome; (5) 

provides consultation and support to 

domestic and international partners on 

the use of vaccines and other prevention 

measures for bacterial respiratory 

diseases; and (6) collaborates with other 

CDC groups, other federal agencies, 

state, tribal, local, and territorial groups, 

ministries of health, World Health 

Organization, private industry, 

academia, and other governmental and 

non-governmental organizations 

involved in public health. 

Delegations of Authority 

All delegations and redelegations of 

authority made to officials and 

employees of affected organizational 

components will continue in them or 

their successors pending further 

redelegation, provided they are 

consistent with this reorganization. 

(Authority: 44 U.S.C. 3101) 

Robin D. Bailey, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2024–21411 Filed 9–18–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–1823–N] 

Medicare Program; Public Meeting for 

New Revisions to the Healthcare 

Common Procedure Coding System 

(HCPCS) Coding—November 6–8, 2024 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), Department 

of Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: This notice announces the 

dates and times of the virtual Healthcare 

Common Procedure Coding System 

(HCPCS) public meeting to be held from 

November 6, 2024, through November 8, 

2024, to discuss CMS’ preliminary 

coding, Medicare benefit category, and 

payment determinations, if applicable, 

for new revisions to the HCPCS Level II 

code set for non-drug and non-biological 

items and services, as well as how to 

register for those meetings. 

DATES: Virtual Meeting Dates: 

Wednesday, November 6, 2024, 9 a.m. 

to 5 p.m. Eastern Time (ET); Thursday, 

November 7, 2024, 9 a.m. to 5 p.m. ET; 

and Friday, November 8, 2024, 9 a.m. to 

5 p.m. ET. 

ADDRESSES: Virtual Meeting Location: 

The HCPCS public meetings will be 

held virtually via Zoom only. 

FOR FURTHER INFORMATION CONTACT: 

Sundus Ashar, (410) 786–0750, 

Sundus.ashar1@cms.hhs.gov, or 

HCPCS@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

On December 21, 2000, Congress 

enacted the Medicare, Medicaid, and 

the Children’s Health Insurance 

Program (CHIP) Benefits Improvement 

and Protection Act of 2000 (BIPA) (Pub. 

L. 106–554). Section 531(b) of BIPA 

mandated that the Secretary establish 

procedures that permit public 

consultation for coding and payment 

determinations for new durable medical 

equipment (DME) under Medicare Part 

B of title XVIII of the Social Security Act 

(the Act). In the November 23, 2001, 

Federal Register (66 FR 58743), we 

published a notice providing 

information regarding the establishment 

of the annual public meeting process for 

DME. 

In 2020, we implemented changes to 

our HCPCS Level II coding procedures, 

including the establishment of quarterly 

coding cycles for drugs and biological 

products and biannual coding cycles for 

non-drug and non-biological items and 

services. 

In the December 28, 2021, Federal 

Register (86 FR 73860), we published a 

final rule that established procedures for 

making Medicare benefit category and 

payment determinations for new items 

and services that are DME, prosthetic 

devices, orthotics and prosthetics, 

therapeutic shoes and inserts, surgical 

dressings, or splints, casts, and other 

devices used for reductions of fractures 

and dislocations under Medicare Part B. 

II. Public Meeting Agendas 

Prior to registering to attend a virtual 

public meeting, all potential 

participants and other attendees are 

advised to review the public meeting 

agendas at https://www.cms.gov/ 

Medicare/Coding/MedHCPCSGenInfo/ 

HCPCSPublicMeetings, which identify 

CMS’ preliminary coding, Medicare 

benefit category, and payment 

determinations, if applicable, and the 

date each item will be discussed. In 

establishing the public meeting agendas, 

CMS may group multiple, related code 

applications under the same agenda 

item. 

III. Virtual Meeting Registration 

The November 6, 2024 through 

November 8, 2024, HCPCS public 

meetings will be virtual and available 

for remote audio attendance and 

participation only via Zoom. The Zoom 

link and registration instructions will be 

posted in the Guidelines for 

Participation in HCPCS Public Meetings 

document on the CMS website at 

https://www.cms.gov/Medicare/Coding/ 

MedHCPCSGenInfo/HCPCSPublic

Meetings and in an announcement on 

the HCPCS General Information page at 

https://www.cms.gov/medicare/codingbilling/healthcare-common-proceduresystem. The same website also contains 

detailed information on how attendees 

can join the virtual public meetings 

using Zoom, including dial-in 

information. All individuals who plan 

to speak (15 or 5 minutes) at the virtual 

public meetings must register by 5 p.m. 

ET on October 25, 2024. All participants 

and other attendees can access the 

virtual public meeting through the 

Zoom link, which will be posted on the 

HCPCS Level II website. Attendees can 

attend more than 1 day of the public 

meeting. 

A. Required Information for Registration 

The following information must be 

provided when registering to be a 

speaker: 

• Name; 

• Company name (if applicable); 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 182 / Thursday, September 19, 2024 / Notices 76839 

• Agenda item and application 

number; 

• Email address; 

• Any special assistance requests 

(will be considered if the registration is 

submitted by 5 p.m. ET, October 25, 

2024); 

• Whether the registrant is a primary 

speaker or a 5-minute speaker for an 

agenda item; and 

• Whether the primary speaker will 

use a PowerPoint presentation. 

B. Speakers and Attendees 

1. Primary Speakers 

Each applicant that submitted a 

HCPCS Level II code application that 

will be discussed at the virtual public 

meetings is permitted to designate a 

primary speaker. Fifteen minutes is the 

total time interval for a primary speaker 

per agenda item. Any unused time from 

the primary speaker will be forfeited 

and cannot be delegated to another 

speaker. The deadline for primary 

speakers to register and submit any 

supporting PowerPoint presentation is 5 

p.m. ET, October 25, 2024. CMS will 

accept PowerPoint presentations if those 

materials are emailed to HCPCS@

cms.hhs.gov by the stated deadline. Due 

to the timeframe needed for the 

planning and coordination of the 

HCPCS virtual public meetings, 

materials that are not submitted in 

accordance with this deadline cannot be 

accommodated. 

All PowerPoint presentation materials 

must not exceed 10 slides and should be 

in PowerPoint presentation format, not 

PDF. We will not play videos, 

transitions, or animations during the 

public meeting sessions and request that 

the speakers exclude these materials 

from their PowerPoint presentation and 

instead submit any relevant video or 

animation materials along with their 

written comments. We request that 

speakers ensure the presentation does 

not include any inappropriate content 

before submission. 

Every primary speaker must declare at 

the beginning of their presentation at 

the meeting, as well as in their written 

summary, whether they have any 

financial involvement with the 

manufacturer of the item that is the 

subject of the HCPCS Level II 

application that the primary speaker 

presented, or any competitors of that 

manufacturer with respect to the item. 

This includes any payment, salary, 

remuneration, or benefit provided to 

that speaker by the applicant. 

2. 5-Minute Speakers 

Any individual related to the public 

meeting agenda item, including but not 

limited to, an employee, interested 

parties, competitor, insurer, public 

consumer, etc., may register and speak 

as a 5-minute speaker. The deadline for 

registering to be a 5-minute speaker is 

5 p.m. ET, October 25, 2024. 

Every 5-minute speaker must declare 

at the beginning of their presentation at 

the meeting, as well as in their written 

summary, whether they have any 

financial involvement with the 

manufacturer of the item that is the 

subject of the HCPCS Level II code 

application or agenda item that the 5- 

minute speaker presented, or with any 

competitors of that manufacturer with 

respect to the item. This includes any 

payment, salary, remuneration, or 

benefit provided to that speaker by the 

applicant. We will not accept any other 

written materials, outside of the written 

comments, from a 5-minute speaker. 

3. All Other Attendees 

All individuals who plan to attend the 

virtual public meetings to listen and do 

not plan to speak, may access the virtual 

public meeting using the Zoom link 

posted on the HCPCS Level II website at 

https://www.cms.gov/medicare/codingbilling/healthcare-common-proceduresystem as well as the guidelines 

document. 

Individuals who require special 

assistance must register and request 

special assistance services by 5 p.m. ET, 

October 25, 2024. 

IV. Written Comments 

The primary and 5-minute speaker(s) 

must email a brief, written summary 

(one paragraph) of their comments and 

conclusions. Written comments from 

anyone, including the primary and 5- 

minute speaker(s), will only be accepted 

when emailed to: HCPCS@cms.hhs.gov 

before 5 p.m. ET on the date of the 

virtual public meeting at which the 

HCPCS Level II code application that is 

the subject of the comments is 

discussed. 

V. Additional Information 

The HCPCS section of the CMS 

website also includes details regarding 

the public meeting process for new 

revisions to the HCPCS Level II code set, 

including information on how to join 

the meeting remotely, and guidelines for 

an effective presentation. The HCPCS 

section of the CMS website also 

contains a document titled ‘‘Healthcare 

Common Procedure Coding System 

(HCPCS) Level II Coding Procedures 

(PDF),’’ which is a description of the 

HCPCS Level II coding process, 

including a detailed explanation of the 

procedures CMS uses to make HCPCS 

Level II coding determinations. 

When CMS refers to a HCPCS code or 

HCPCS Level II coding application 

above, CMS may also be referring to 

circumstances when a HCPCS code has 

already been issued, but a Medicare 

benefit category and/or payment has not 

been determined. CMS is working 

diligently to address Medicare benefit 

category and payment determinations 

for new items and services that may be 

DME, prosthetic devices, orthotics and 

prosthetics, therapeutic shoes and 

inserts, surgical dressings, or splints, 

casts, and other devices used for 

reductions of fractures and dislocations 

under Medicare Part B. Please check the 

CMS website listed above for the final 

agenda. 

VI. Collection of Information 

Requirements 

This document does not impose 

information collection requirements, 

that is, reporting, recordkeeping, or 

third-party disclosure requirements. 

Consequently, there is no need for 

review by the Office of Management and 

Budget under the authority of the 

Paperwork Reduction Act of 1995 (44 

U.S.C. 3501 et seq.). 

The Administrator of CMS, Chiquita 

Brooks-LaSure, having reviewed and 

approved this document, authorizes 

Trenesha Fultz-Mimms, who is the 

Federal Register Liaison, to 

electronically sign this document for 

purposes of publication in the Federal 

Register. 

Trenesha Fultz-Mimms, 

Federal Register Liaison, Centers for Medicare 

& Medicaid Services. 

[FR Doc. 2024–21297 Filed 9–18–24; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3464–FN] 

Medicare Program; Application by the 

National Association of Boards of 

Pharmacy (NABP) for Continued CMS 

Approval of Its Home Infusion Therapy 

(HIT) Accreditation Program 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), Health and 

Human Services (HHS). 

ACTION: Final notice. 

SUMMARY: This final notice announces 

our decision to approve the National 

Association of Boards of Pharmacy 

(NABP) for continued recognition as a 

national accrediting organization that 

accredits suppliers of home infusion 


lotter on DSK11XQN23PROD with NOTICES1